Blancas, I., Legerén, M., Córdoba, L. C., Gonzalez, C. J. R., Rodríguez-Serrano, F. (2025). Cost-effectiveness of HER2/neu 655 genotyping in managing trastuzumab-induced cardiotoxicity risk in HER2-positive breast cancer patients.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.543